Development of a Novel Chemical Site-Specific ADC Conjugation Platform with Enhanced Therapeutic Window

Time: 9:00 am


• Evaluating site-specific technologies that are being employed in many of the next generation ADCs due to enhanced biological properties in pre-clinical studies
• Reporting a new method of affinity peptide mediated regiodivergent antibody functionalization that enables the synthesis of ADCs from native IgGs in a tunable and atom-precise manner